EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Umbelliferone's antifungal efficacy against multidrug-resistant Candida albicans: A combined in-vitro and in-silico approach investigating mechanisms of action and therapeutic potential

Megharethnam Kaviraj, K R Jayappriyan

Microbial Pathogenesis · 2026

DOI: 10.1016/j.micpath.2026.108373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Megharethnam Kaviraj und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, India. Hauptthemen laut MEDLINE: Umbelliferones, Antifungal Agents, Candida albicans, Drug Resistance, Multiple, Fungal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Rashtriya Uchchatar Shiksha Abhiyan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of multidrug-resistant Candida albicans poses a significant threat to public health, emphasizing the need for novel antifungal therapies. In this context, plant-derived compounds have emerged as promising candidates, owing to their diverse medicinal properties, including antifungal activity. In the current study, the compound was isolated and purified from Evolvulus alsinoides through fractionation and High-Performance Thin-Layer Chromatography (HPTLC) and characterized using High-Resolution Mass Spectrometry (HRMS), Fourier Transform Infrared Spectroscopy (FTIR), and Nuclear Magnetic Resonance Spectroscopy (NMR) and identified as umbelliferone. The compound exhibited potent anti-candidal activity against both antifungal-susceptible (K1) and multidrug-resistant (K2) strains of C. albicans. The efficacy of the compound revealed the significant inhibitory effects with zones measuring 16 ± 0.57 mm and 14 ± 0.57 mm against K1 and K2 strains, respectively at 1 mg concentration. Furthermore, the minimum inhibitory concentrations were determined to be 125 μg/mL for K1 strain and 175 μg/mL for K2 strain. In-silico studies revealed that umbelliferone met Lipinski's rule requirements and demonstrated favourable ADMET properties as it showed the least binding energy of -6.1 and -5.6 kcal/mol against dihydrofolate reductase (DHFR) and lanosterol 14α-demethylase (ERG11) respectively of the Candida proteins. The molecular dynamics study demonstrated that the DHFR-umbelliferone complex remains stable over time and under physiological conditions throughout a 100 ns simulation. Additionally, gene expression studies revealed that the umbelliferone significantly reduces the expression of DFR1 codes for the protein DHFR with a 0.7-fold decrease in K1 and a 0.5-fold decrease in K2 when compared to the control. These findings highlight umbelliferone as a promising antifungal agent against multidrug-resistant C. albicans, offering a new avenue for drug discovery and development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UmbelliferonesAntifungal AgentsCandida albicansDrug Resistance, Multiple, FungalMicrobial Sensitivity TestsPlant ExtractsMolecular Docking SimulationSpectroscopy, Fourier Transform InfraredApiaceaeComputer SimulationMagnetic Resonance SpectroscopyMass SpectrometryChromatography, Thin Layer

Stichwörter der Autor:innen

Antifungal mechanismCandida albicansEvolvulus alsinoidesGene expressionIn-silico studyUmbelliferone

Substanzen

UmbelliferonesAntifungal Agents7-hydroxycoumarinPlant Extracts

Autor:innen und Institutionen

  • Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, India.
  • Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, India. Electronic address: jayapriyan@gmail.com.

Förderung

  • Rashtriya Uchchatar Shiksha Abhiyan

Zitieren

APA

Kaviraj, M., & Jayappriyan, K. R. (2026). Evaluation of Umbelliferone's antifungal efficacy against multidrug-resistant Candida albicans: A combined in-vitro and in-silico approach investigating mechanisms of action and therapeutic potential. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108373

Vancouver

Kaviraj M, Jayappriyan KR. Evaluation of Umbelliferone's antifungal efficacy against multidrug-resistant Candida albicans: A combined in-vitro and in-silico approach investigating mechanisms of action and therapeutic potential. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108373

BibTeX
@article{Kaviraj2026,
  author = {Kaviraj, Megharethnam and Jayappriyan, K R},
  title = {Evaluation of Umbelliferone's antifungal efficacy against multidrug-resistant Candida albicans: A combined in-vitro and in-silico approach investigating mechanisms of action and therapeutic potential},
  journal = {Microbial Pathogenesis},
  year = {2026},
  doi = {10.1016/j.micpath.2026.108373}
}
Kostenlos starten →